Logotype for Lifecare

Lifecare (LIFE) investor relations material

Lifecare Q3 2025 earnings summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for Lifecare
Q3 2025 earnings summary12 Nov, 2025

Executive summary

  • Secured NOK 80 million in funding, with bridge financing in place until a rights issue planned for January 2026, supporting development and regulatory milestones for implantable CGM technology.

  • Finalized product design and production setup, positioning for near-term veterinary market entry and progressing toward first-in-human clinical approval.

  • Achieved significant milestones: completed human study with MARD of 9.6%, advanced regulatory preparations for CE marking, and entered final regulatory review phase for first-in-human clinical approval.

  • Early results from longevity trials in dogs confirm biocompatibility and reliable glucose data transmission, leading to product improvements.

  • Regulatory review for first-in-human trial is ongoing, with approval expected by December 2025 and trial initiation in Q1 2026.

Financial highlights

  • Q3 2025 revenue and other income totaled NOK 0.5 million, mainly from grants, with YTD 2025 at NOK 1.54 million.

  • Operating expenses for Q3 2025 reached NOK 66.4 million, driven by product development, regulatory compliance, and new production facility costs.

  • Net loss for Q3 2025 was NOK 64.9 million, with cash at quarter-end of NOK 6 million and net cash outflow of NOK 26 million.

  • R&D expenses YTD were NOK 60 million, with stable administrative costs.

  • Total equity was negative NOK 6.7 million at quarter-end, reflecting accumulated losses.

Outlook and guidance

  • Veterinary market launch expected in 1H 2026, with human CE mark and European launch targeted for 2027.

  • Regulatory approval for first-in-human trial anticipated by end of December 2025, with trial commencement in Q1 2026 and pivotal human trials to start mid-2026.

  • Rights issue of NOK 80-100 million planned for January 2026, with bridge loans securing operations until then.

  • Revenue contributions expected from 2027, aligned with commercial timeline.

  • Board considers going concern assumption appropriate based on planned capital measures.

Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.

Next Lifecare earnings date

Logotype for Lifecare
Q4 202520 Feb, 2026
Your earnings 
season toolkit.
Download
Free on both iOS & Android.

Next Lifecare earnings date

Logotype for Lifecare
Q4 202520 Feb, 2026

The essential earnings season companion

The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.

Live calls and transcripts

Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.

Find what you need faster

Search for any keyword across all transcripts simultaneously.

Easily store key findings

Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Your watchlist. Your dashboard.

Follow the companies that matter to you. Get a personalized feed with real-time updates.

Be the first to know

Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.

Consensus estimates

Access analyst consensus estimates, valuation multiples, and revenue segments splits.

All IR material in one place

The easiest way to stay updated during earnings season.

Global coverage

All events from public companies. Live and recorded.

Just click and listen

No webcast links. No manual registrations.

Research anytime, anywhere

Built for professionals. Loved by everyone. Try our free mobile app.

excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com

Frequently asked questions

Lifecare AS is a Norwegian company specializing in the development of medical sensors for health monitoring. The company focuses on creating advanced biosensor technology, including its primary product, a micro-sensor designed for continuous glucose monitoring in diabetic patients. In addition to glucose monitoring, Lifecare develops nanotechnology-based sensors capable of measuring pressure and temperature within live tissue, enhancing health diagnostics and monitoring capabilities. The company is headquartered in Bergen, Norway, and its shares are listed on the Oslo Stock Exchange.

Quartr provides global coverage of all investor relation material from public companies.

  • Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

  • Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.

  • Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.

Yes, the Quartr mobile app is free on both iOS and Android.

Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.

Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.

Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.

Explore our global coverage